Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Evommune Inc. (EVMN)

ADC Therapeutics SA and Evommune Inc. are both Biotechnology companies. Evommune Inc. is the larger, with a market value of $215.2M against $190.2M — 1.1× the size. Evommune Inc. has the higher net margin (0.00% vs −121.8%) and the lower return on invested capital (−82.5% vs 0.00%). Across the 12 metrics below, ADC Therapeutics SA leads on 6 and Evommune Inc. on 6.

Valuation

Metric ADCT EVMN Biotechnology median
P/E n/m n/m 8.42
P/S 2.90 n/m 10.01
P/B n/m 0.77 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 1.61 n/m 9.41
Earnings yield (44.30%) (186.00%) (31.85%)
Free cash flow yield (44.04%) (34.84%) (24.58%)

Profitability

Metric ADCT EVMN Biotechnology median
Gross margin 88.86% — 65.16%
Operating margin (125.08%) 0.00% 0.00%
Net margin (121.77%) 0.00% 0.00%
Free cash flow margin (127.72%) 0.00% 0.00%
Return on equity 45.35% (141.99%) (56.36%)
Return on assets (32.25%) (62.71%) (48.04%)
Return on invested capital 0.00% (82.46%) 0.00%

Growth

Metric ADCT EVMN Biotechnology median
Revenue growth (TTM) 3.03% — 6.02%
EPS growth (last fiscal year) 30.86% 75.23% 30.26%
Revenue growth, 5-year CAGR 103.35% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ADCT EVMN Biotechnology median
Debt to equity (0.51) 0.00 0.00
Current ratio 3.03 11.68 4.72
Net debt to EBITDA 1.22 1.87 0.96

Dividend

Metric ADCT EVMN Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ADCT EVMN Biotechnology median
Market cap 190.23m 215.22m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack